Latest Articles

Publication Date
Reliability and validity of the 30-second chair-stand test for assessing functional capacity in women with endometriosis: a cross-sectional and longitudinal study.

and Hypothesis: Endometriosis often causes pelvic pain, limiting movement and physical function. Performance-based tests are fundamental to measure functional status among these women. This study aimed to evaluate the reliability …

Published: Aug. 1, 2026, midnight
Expression Profiling of Immune-Related Genes in Different Samples from Patients with Endometriosis Revealed Upregulation of THBS1, CHGB and CYR61.

Endometriosis is a chronic, inflammatory, estrogen-dependent disease that affects approximately 6-10% of women of reproductive age. The present study aimed to investigate the expression of 48 immune-related genes in different …

Published: Aug. 1, 2026, midnight
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Proactive financial news

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Proactive financial news

Published: July 31, 2026, 3:20 p.m.
Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial - Yahoo Finance UK

Medicus Pharma receives UAE approval for Phase 2a Endometriosis trial Yahoo Finance UK

Published: July 31, 2026, 3:09 p.m.
Medicus Pharma gets UAE approval for Phase 2a t... - Pluang

Medicus Pharma gets UAE approval for Phase 2a t... Pluang

Published: July 31, 2026, 1:44 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - Yahoo! Finance Canada

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix Yahoo! Finance Canada

Published: July 31, 2026, 1:24 p.m.
Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix - ca.finance.yahoo.com

Medicus Pharma receives UAE authorization for Phase 2a endometriosis study of Teverelix ca.finance.yahoo.com

Published: July 31, 2026, 1:24 p.m.
Medicus Pharma gets UAE approval for Phase 2a p... - Pluang

Medicus Pharma gets UAE approval for Phase 2a p... Pluang

Published: July 31, 2026, 12:04 p.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - Quiver Quantitative

Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix Quiver Quantitative

Published: July 31, 2026, 11:40 a.m.
Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix - quiverquant.com

Medicus Pharma Receives UAE IND Authorization for PRECISION-E2 Phase 2a Endometriosis Study of Teverelix quiverquant.com

Published: July 31, 2026, 11:40 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!